Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibition of herpes simplex virus replication by anthracycline compounds.

R J Ash1, K A Diekema

  • 1Merrell Dow Research Institute, Cincinnati, Ohio.

Antiviral Research
|September 1, 1987
PubMed
Summary

Anthracycline compounds effectively inhibit herpes simplex virus (HSV) replication by over 99.9%. Certain modified anthracyclines show promise as novel anti-herpes agents, with efficacy independent of host DNA synthesis inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of myeloperoxidase release from rat polymorphonuclear leukocytes by a series of azachalcone derivatives.

Journal of medicinal chemistry·1994
Same author

The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.

British journal of pharmacology·1990
Same author

The chiral synthesis and biochemical properties of electron rich phenolic sulfoxide analogs of sparsomycin.

Biochemical and biophysical research communications·1990
Same author

Butyrate-induced reversal of herpes simplex virus restriction in neuroblastoma cells.

Virology·1986
Same author

Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.

Surgery·1986
Same author

Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferase.

Biochemical and biophysical research communications·1984

Area of Science:

  • Virology
  • Pharmacology
  • Molecular Biology

Background:

  • Herpes simplex virus (HSV) causes significant human infections.
  • Existing antiviral therapies face challenges with resistance and side effects.
  • Anthracyclines are a class of compounds with known biological activities.

Purpose of the Study:

  • To investigate the antiviral activity of anthracycline compounds against HSV.
  • To compare the efficacy of different anthracycline derivatives.
  • To elucidate the mechanism of antiviral action.

Main Methods:

  • Viral replication assays using type 1 and type 2 HSV strains.
  • Host cell-dependent inhibition studies.
  • Direct virion inactivation assays.

Related Experiment Videos

  • Cesium chloride density gradient analysis of viral DNA synthesis.
  • Host DNA synthesis inhibition assays.

    • Main Results:

    • Low concentrations (0.1-0.2 microM) of anthracyclines inhibited HSV replication by >99.9%.
    • N,N-dimethyl daunomycin (NDMD) was more potent than daunomycin (DM) or adriamycin (AD).
    • Inhibition occurred via blocking viral DNA synthesis, not solely by suppressing host DNA synthesis.
    • Anthracyclines retained effectiveness when added late in the infectious cycle.

    Conclusions:

    • Anthracyclines demonstrate potent antiviral activity against HSV.
    • NDMD shows superior efficacy and may act via a different mechanism than DM or AD.
    • Anthracyclines with sugar moiety substitutions are potential anti-herpes agents.